Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Get up to date on 2024 wash sale rules for Dividend Etfs and how they affect harvesting strategies and reporting requirements.
15,381 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
As signs point to a softer economy in 2026, dividend-focused ETFs can provide ballast. This guide identifies three re...
In a choppy market, a dependable income stock is turning heads in 2026. This article breaks down why this resilient d...
Looking for steady, dependable income from your investments? This guide shows how to locate an industrial stock with ...
Choosing between VYM and VIG comes down to income now vs. growth later. This guide breaks down how each ETF targets d...
NVIDIA just raised dividend marks a bold shift in capital allocation as AI demand surges. This guide breaks down what...
This year’s top-performing Vanguard ETF grabbed headlines with eye-catching gains. Before you dive in, learn three re...
When market swings push shares lower, brilliant dividend stocks can become compelling long-term buys. This article ex...
When a tech CEO sells stock, investors pay attention. This article breaks down the implications of Adobe CEO Shantanu...
When a chief financial officer sells a sizable stake, investors take notice. This article breaks down Shoals Technolo...
A recent SEC Form 4 shows a Teladoc executive sold roughly $71,000 worth of stock. This article breaks down what that...
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...